BioCentury | Aug 11, 2008
Finance

Bringing back the mo’

...emerged as buyers in late July. He added that two momentum players, Freiss Associates and Mazama Capital...
BioCentury | Jun 13, 2003
Financial News

Dendreon raises $26.7 million

...million in a private placement of 3.8 million shares at $7. Investors included Baystar Capital; Mazama Capital...
BioCentury | Jul 1, 2002
Finance

Ebb & Flow

...13.6%) of drug delivery play DepoMed (DMI), which closed Friday at $3.09 . . . Mazama Capital...
BioCentury | Mar 25, 2002
Finance

Who's left?

...Perseus 1,032,043 4.5% Soros Fund 673,146 3.0% Barclays Global Investors 449,700 2.0% Galleon 432,100 1.9% Mazama Capital...
Items per page:
1 - 4 of 4
BioCentury | Aug 11, 2008
Finance

Bringing back the mo’

...emerged as buyers in late July. He added that two momentum players, Freiss Associates and Mazama Capital...
BioCentury | Jun 13, 2003
Financial News

Dendreon raises $26.7 million

...million in a private placement of 3.8 million shares at $7. Investors included Baystar Capital; Mazama Capital...
BioCentury | Jul 1, 2002
Finance

Ebb & Flow

...13.6%) of drug delivery play DepoMed (DMI), which closed Friday at $3.09 . . . Mazama Capital...
BioCentury | Mar 25, 2002
Finance

Who's left?

...Perseus 1,032,043 4.5% Soros Fund 673,146 3.0% Barclays Global Investors 449,700 2.0% Galleon 432,100 1.9% Mazama Capital...
Items per page:
1 - 4 of 4